Last updated on July 2019

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis


Brief description of study

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

Clinical Study Identifier: NCT03523858

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.